Journal of Biological Chemistry · 2006 · 88 citations · 30 references
Life SciencesCell BiologyMolecular BiologyCell SignalingGene ExpressionSignal TransductionCalcium SignalingIntracellular Calcium SignalingIon Channel ExpressionIon Channel RegulationMuscle DifferentiationRna InterferenceCa2+ SignalingCalcium Signaling In Muscle CellsExcitation-contraction CouplingMyoblast DifferentiationSkeletal Muscle DifferentiationSkeletal Muscle PhysiologyStore-operated Calcium EntryTransient Receptor Potential Channels
We have shown that TRPC3 (transient receptor potential channel canonical type 3) is sharply up-regulated during the early part of myotube differentiation and remains elevated in mature myotubes compared with myoblasts. To examine its functional roles in muscle, TRPC3 was “knocked down” in mouse primary skeletal myoblasts using retroviral-delivered small interference RNAs and single cell cloning. TRPC3 knockdown myoblasts (97.6 ± 1.9% reduction in mRNA) were differentiated into myotubes (TRPC3 KD) and subjected to functional and biochemical assays. By measuring rates of Mn2+ influx with Fura-2 and Ca2+ transients with Fluo-4, we found that neither excitation-coupled Ca2+ entry nor thapsigargin-induced store-operated Ca2+ entry was significantly altered in TRPC3 KD, indicating that expression of TRPC3 is not required for engaging either Ca2+ entry mechanism. In Ca2+ imaging experiments, the gain of excitation-contraction coupling and the amplitude of the Ca2+ release seen after direct RyR1 activation with caffeine was significantly reduced in TRPC3 KD. The decreased gain appears to be due to a decrease in RyR1 Ca2+ release channel activity, because sarcoplasmic reticulum (SR) Ca2+ content was not different between TRPC3 KD and wild-type myotubes. Immunoblot analysis demonstrated that TRPC1, calsequestrin, triadin, and junctophilin 1 were up-regulated (1.46 ± 1.91-, 1.42 ± 0.08-, 2.99 ± 0.32-, and 1.91 ± 0.26-fold, respectively) in TRPC3 KD. Based on these data, we conclude that expression of TRPC3 is tightly regulated during muscle cell differentiation and propose that functional interaction between TRPC3 and RyR1 may regulate the gain of SR Ca2+ release independent of SR Ca2+ load. We have shown that TRPC3 (transient receptor potential channel canonical type 3) is sharply up-regulated during the early part of myotube differentiation and remains elevated in mature myotubes compared with myoblasts. To examine its functional roles in muscle, TRPC3 was “knocked down” in mouse primary skeletal myoblasts using retroviral-delivered small interference RNAs and single cell cloning. TRPC3 knockdown myoblasts (97.6 ± 1.9% reduction in mRNA) were differentiated into myotubes (TRPC3 KD) and subjected to functional and biochemical assays. By measuring rates of Mn2+ influx with Fura-2 and Ca2+ transients with Fluo-4, we found that neither excitation-coupled Ca2+ entry nor thapsigargin-induced store-operated Ca2+ entry was significantly altered in TRPC3 KD, indicating that expression of TRPC3 is not required for engaging either Ca2+ entry mechanism. In Ca2+ imaging experiments, the gain of excitation-contraction coupling and the amplitude of the Ca2+ release seen after direct RyR1 activation with caffeine was significantly reduced in TRPC3 KD. The decreased gain appears to be due to a decrease in RyR1 Ca2+ release channel activity, because sarcoplasmic reticulum (SR) Ca2+ content was not different between TRPC3 KD and wild-type myotubes. Immunoblot analysis demonstrated that TRPC1, calsequestrin, triadin, and junctophilin 1 were up-regulated (1.46 ± 1.91-, 1.42 ± 0.08-, 2.99 ± 0.32-, and 1.91 ± 0.26-fold, respectively) in TRPC3 KD. Based on these data, we conclude that expression of TRPC3 is tightly regulated during muscle cell differentiation and propose that functional interaction between TRPC3 and RyR1 may regulate the gain of SR Ca2+ release independent of SR Ca2+ load. TRPCs are one family of transient receptor potential (TRP) 2The abbreviations used are: TRPC3, transient receptor potential channel canonical type 3; TRPC3 KD, TRPC3 knockdown; RyR, ryanodine receptor; DHPR, dihydropyridine receptor; IP3R, inositol 1,4,5-trisphosphate receptor; SOCE, store-operated calcium entry; ECCE, excitation-coupling calcium entry; EC coupling, excitation-contraction coupling; SR, sarcoplasmic reticulum; JP1, junctophilin type 1; CSQ, calsequestrin; HEK, human embryonic kidney. cation channels. This entire group of channels has been predicted to consist of six transmembrane segment channels that allow the entry of Ca2+ and Na+ into the cell (1Ramsey I.S. Delling M. Clapham D.E. Annu. Rev. Physiol. 2006; 68: 619-647Crossref PubMed Scopus (1240) Google Scholar, 2Pedersen S.F. Owsianik G. Nilius B. Cell Calcium. 2005; 38: 233-252Crossref PubMed Scopus (616) Google Scholar, 3Freichel M. Vennekens R. Olausson J. Stolz S. Philipp S.E. Weissgerber P. Flockerzi V. J. Physiol. 2005; 567: 59-66Crossref PubMed Scopus (83) Google Scholar). One of the TRPC subtypes, TRPC3, is highly expressed in the brain, skeletal muscle, and cardiac muscle (4Clapham D.E. Nature. 2003; 426: 517-524Crossref PubMed Scopus (2164) Google Scholar, 5Hofmann T. Schaefer M. Schultz G. Gudermann T. J. Mol. Med. 2000; 78: 14-25Crossref PubMed Scopus (117) Google Scholar, 6Vandebrouck C. Martin D. Colson-Van Schoor M. Debaix H. Gailly P. J. Cell Biol. 2002; 158: 1089-1096Crossref PubMed Scopus (283) Google Scholar). It has been reported that TRPC3-mediated Ca2+ entry can be induced by two different mechanisms: 1) direct activation by binding of exogenous organic molecules or endogenous metabolites such as diacylglycerol analogues (7Hofmann T. Obukhov A.G. Schaefer M. Harteneck C. Gudermann T. Schultz G. Nature. 1999; 397: 259-263Crossref PubMed Scopus (1268) Google Scholar), and 2) phospholipase C-mediated activation via phospholipase C-coupled receptor. The latter mechanism can be subdivided into two different submechanisms. One submechanism is store-operated Ca2+ entry (SOCE) (8Li H.S. Xu X.Z. Montell C. Neuron. 1999; 24: 261-273Abstract Full Text Full Text PDF PubMed Scopus (292) Google Scholar, 9Vazquez G. Lievremont J.P. St. J. Bird G. Putney Jr., J.W. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 11777-11782Crossref PubMed Scopus (155) Google Scholar, 10Yildirim E. Kawasaki B.T. Birnbaumer L. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 3307-3311Crossref PubMed Scopus (36) Google Scholar) (for example, when Ca2+ store depletion through IP3R by phospholipase C pathway triggers TRPC3 activation). The second submechanism is receptor-operated Ca2+ entry (11Okada T. Inoue R. Yamazaki K. Maeda A. Kurosaki T. Yamakuni T. Tanaka I. Shimizu S. Ikenaka K. Imoto K. Mori Y. J. Biol. Chem. 1999; 274: 27359-27370Abstract Full Text Full Text PDF PubMed Scopus (402) Google Scholar, 12Zhu X. Jiang M. Birnbaumer L. J. Biol. Chem. 1998; 273: 133-142Abstract Full Text Full Text PDF PubMed Scopus (307) Google Scholar, 13Philipp S. Strauss B. Hirnet D. Wissenbach U. Mery L. Flockerzi V. Hoth M. J. Biol. Chem. 2003; 278: 26629-26638Abstract Full Text Full Text PDF PubMed Scopus (124) Google Scholar) (for example, in B lymphocytes, when TRPC3 is activated by physical coupling with phospholipase C γ2 and is responsible for the secondary intracellular Ca2+ entry after B-cell receptor activation) (14Nishida M. Sugimoto K. Hara Y. Mori E. Morii T. Kurosaki T. Mori Y. EMBO J. 2003; 22: 4677-4688Crossref PubMed Scopus (94) Google Scholar). Physiological evidence has been demonstrated for the involvement of TRPC3 in many processes. For example, TRPC3 activation via phospholipase C γ-IP3R pathway is essential for brain-derived neurotrophic factor-dependent growth cone guidance in cerebellar granule neurons (15Li Y. Jia Y.C. Cui K. Li N. Zheng Z.Y. Wang Y.Z. Yuan X.B. Nature. 2005; 434: 894-898Crossref PubMed Scopus (374) Google Scholar). In arterial smooth muscle cells, TRPC3 is activated by purinergic receptors, and then Ca2+ influx through TRPC3 induces depolarization and vasoconstriction (16Reading S.A. Earley S. Waldron B.J. Welsh D.G. Brayden J.E. Am. J. Physiol. 2005; 288: H2055-H2061Crossref PubMed Scopus (143) Google Scholar). Using heterologous expression studies in HEK 293 cells, it has been shown that TRPC3 physically interacts with cytosolic Ca2+ signaling proteins such as IP3R, where it competes with calmodulin for the same binding site on IP3R (17Zhang Z. Tang J. Tikunova S. Johnson J.D. Chen Z. Qin N. Dietrich A. Stefani E. Birnbaumer L. Zhu M.X. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 3168-3173Crossref PubMed Scopus (208) Google Scholar). In addition, it has been reported that TRPC3 interacts with ryanodine receptors (RyRs) (18Kiselyov K.I. Shin D.M. Wang Y. Pessah I.N. Allen P.D. Muallem S. Mol. Cell. 2000; 6: 421-431Abstract Full Text Full Text PDF PubMed Scopus (141) Google Scholar, 19Lee E.H. Allen P.D. Biophys. J. 2004; 86 (abstr.): 61Google Scholar); however, the functional roles of TRPC3 in skeletal muscle have not been well addressed. RyRs function as Ca2+ release channels in the sarcoplasmic reticulum (SR) and are essential proteins for excitation-contraction (EC) coupling in striated muscles (20Brady A.J. Annu. Rev. Physiol. 1964; 26: 341-356Crossref PubMed Scopus (20) Google Scholar, 21Sandow A. Pharmacol. Rev. 1965; 17: 265-320PubMed Google Scholar). RyRs have been shown to have bidirectional communication with a second essential protein in EC coupling, the dihydropyridine receptor (DHPR), which acts as both a sarcolemmal L-type voltage-gated Ca2+ channel (20Brady A.J. Annu. Rev. Physiol. 1964; 26: 341-356Crossref PubMed Scopus (20) Google Scholar) and the mechanical trigger for RyR activation (21Sandow A. Pharmacol. Rev. 1965; 17: 265-320PubMed Google Scholar). During EC coupling, as a result of membrane depolarization, Ca2+ influx through DHPR or conformational changes of DHPR via its gating charge movement activates RyR2 in cardiac muscle or RyR1 in skeletal muscle respectively. The Ca2+ stored in SR is then released through RyRs into the cytosol to cause muscle contraction. Recently, functional coupling between RyR and TRPC1 (22Sampieri A. Diaz-Munoz M. Antaramian A. Vaca L. J. Biol. Chem. 2005; 280: 24804-24815Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar) or TRPC3 (18Kiselyov K.I. Shin D.M. Wang Y. Pessah I.N. Allen P.D. Muallem S. Mol. Cell. 2000; 6: 421-431Abstract Full Text Full Text PDF PubMed Scopus (141) Google Scholar) has been shown in heterologous expression systems such as Chinese hamster ovary and HEK cells. In the case of TRPC1, it has been proposed that the functional interaction between RyR1 and TRPC1 is a physical interaction with an undefined region in the cytoplasmic foot region of RyR1 (22Sampieri A. Diaz-Munoz M. Antaramian A. Vaca L. J. Biol. Chem. 2005; 280: 24804-24815Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar). Furthermore, involvement of TRPCs has been reported in the abnormal calcium influx observed in muscle disease models such as dystrophic mouse skeletal muscle fibers (6Vandebrouck C. Martin D. Colson-Van Schoor M. Debaix H. Gailly P. J. Cell Biol. 2002; 158: 1089-1096Crossref PubMed Scopus (283) Google Scholar). Therefore, although in skeletal muscle it is possible for EC coupling to occur in the absence of extracellular Ca2+ (21Sandow A. Pharmacol. Rev. 1965; 17: 265-320PubMed Google Scholar), the possible involvement of extracellular Ca2+ influx and the interactions of RyR1 with Ca2+ ion-conducting channel proteins in sarcolemma (other than the DHPR) during EC coupling still remain to be elucidated. In the current study, we have defined the role of TRPC3 during EC coupling and muscle contraction in primary mouse skeletal muscle myoblasts/myotubes in which TRPC3 mRNA and protein expression was reduced (>97 and >94%, respectively) by using small interference RNA. Materials—Fetal bovine serum, cell culture media, trypsin, l-glutamine, penicillin/streptomycin, and basic fibroblast growth factor were obtained from Invitrogen. Caffeine, KCl, ryanodine, thapsigargin, cyclopiazonic acid, and heat-inactivated horse serum were obtained from Sigma-Aldrich. Monoclonal anti-RyR1 antibody (34C) was provided by Drs. J. Airey and J. Sutko (Developmental Studies Hybridoma Bank, Iowa City, IA). Anti-TRPC3 antibody was obtained from Alomone Labs (Jerusalem, Israel). Anti-DHPR, sarcoplasmic reticulum calcium ATPase (SERCA), triadin, and calsequestrin antibodies were obtained from Affinity BioReagents (Golden, CO). Anti-junctophilin 1 antibody was a kind gift from Dr. Jianjie Ma. Anti-calmodulin, FKBP12, and α-tubulin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). G-Sepharose beads were obtained from Amersham Biosciences. Collagen was purchased from Upstate Biotechnology (Lake Placid, NY). FuGENE transfection reagent was obtained from Roche Diagnostics. Cell Cultures—The method used to derive primary wild-type myoblasts from mouse skeletal muscle was previously described (23Felder E. Protasi F. Hirsch R. Franzini-Armstrong C. Allen P.D. Biophys. J. 2002; 82: 3144-3149Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar, 24Moore R.A. Nguyen H. Galceran J. Pessah I.N. Allen P.D. J. Cell Biol. 1998; 140: 843-851Crossref PubMed Scopus (60) Google Scholar, 25Lee E.H. Lopez J.R. Li J. Protasi F. Pessah I.N. Kim D.H. Allen P.D. Am. J. Physiol. 2004; 286: C179-C189Crossref PubMed Scopus (34) Google Scholar). After ∼48 h in growth medium, myoblasts were replated either on 10-cm dishes coated with collagen to prepare cell lysates or on 96-well plates coated with collagen for Ca2+ imaging and Mn2+ quench experiments. growth was with differentiation heat-inactivated horse serum and growth and into an to were in a in with bovine serum, of and of of TRPC3 the mRNA of TRPC3 in primary were two different were using a from on the of TRPC3 that the not to of two and was into a CA). were by into with FuGENE transfection and the was with The (TRPC3 KD and was stored mouse skeletal muscle myoblasts were for h with both TRPC3 KD and and on and using was and differentiated into myotubes described in from myoblasts and differentiated myotubes of TRPC3 KD was subjected to to and by The of with of and of in a were in The were for for and of for and for 1 and were with the City, CA). Ca2+ and Mn2+ transients Ca2+ and Mn2+ influx were as described previously E.H. Lopez J.R. Li J. Protasi F. Pessah I.N. Kim D.H. Allen P.D. Am. J. Physiol. 2004; 286: C179-C189Crossref PubMed Scopus (34) Google Scholar, J.D. Wang Y. R.A. Chen Allen P.D. Pessah I.N. Biophys. J. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, E. H. D. C. T. J. J. Biol. Chem. Full Text PDF PubMed Google Scholar). differentiated primary wild-type and TRPC3 KD myotubes were with for Ca2+ imaging and Fura-2 for Mn2+ quench myotubes were with an with a Caffeine, KCl, cyclopiazonic acid, ryanodine, and were in imaging or and to myotubes by a CA). To in the case of the of Na+ was and the was was as previously described E.H. Allen P.D. Kim D.H. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus (38) Google Scholar). myotubes were and with a 1 1 of of and of to prepare the cell For triadin, Ca2+ of the was by The cell was then to and the protein of the was protein of with was with of antibody by with protein G-Sepharose beads for were with the to The were with and subjected to and are as ± S.E. with the of in the of the was by the or were to be when were using of TRPC3 mRNA of different TRPC3 knockdown were subjected to and then to examine TRPC3 mRNA The was ± 1.9% reduction in the mRNA Immunoblot analysis with cell from myotubes ± reduction in the protein This was TRPC3 KD and used for functional and biochemical experiments. of TRPC3 cytosolic Ca2+ transients in to depolarization and direct RyR1 activation in TRPC3 KD myotubes with myotubes were used as a To the membrane depolarization of muscle, was to myotubes for TRPC3 KD myotubes a decrease in amplitude of Ca2+ release compared with wild-type myotubes amplitude of TRPC3 KD myotubes was ± when the amplitude of wild-type myotubes was to that the gain of EC coupling was reduced in the absence of TRPC3 compared with of wild-type myotubes that the transients in TRPC3 KD myotubes a which was by significantly decreased of after by a in amplitude in TRPC3 KD myotubes ± (TRPC3 KD ± To the that the cause of the reduced cytosolic Ca2+ release during EC coupling was due to a reduced of SR Ca2+ in TRPC3 KD SR Ca2+ content was by of the myotubes with cyclopiazonic acid, an SR was in the of Ca2+ in the SR of TRPC3 KD myotubes compared with that of wild-type myotubes and We that be responsible for the reduced gain of EC The we was that of an of RyR1 RyR1 was by the myotubes with a of the channel caffeine and measuring the of the Ca2+ transient We found that the amplitude of the cytosolic Ca2+ by caffeine was significantly in TRPC3 KD myotubes compared with wild-type myotubes and when a of TRPC3 KD myotubes the of type to 1) was with that of wild-type myotubes the of after caffeine by a in amplitude was ± (TRPC3 KD) ± that although the amplitude was significantly the of RyR1 in TRPC3 KD myotubes were to of wild-type myotubes. The second was that TRPC3 be the to be excitation-coupling calcium entry channel G. J.D. E.H. Allen P.D. Pessah I.N. Proc. Natl. Acad. Sci. U. S. A. 2004; PubMed Scopus Google Scholar) and that the decrease in gain and decreased after was secondary to a decrease in Ca2+ We using Mn2+ quench in myotubes with Fura-2 with or ryanodine for to RyR1 was to myotubes to membrane depolarization in the of extracellular and the of Mn2+ quench the Fura-2 was We found that the of in TRPC3 KD myotubes was not significantly different from that of wild-type myotubes ± (TRPC3 KD) ± that TRPC3 is not the channel and not with the or a role in the communication the DHPR, and the of SR with cyclopiazonic is to we the of TRPC3 with This was in myotubes with in which SR Ca2+ been previously by the of in the absence of extracellular After store depletion was by the of to or Ca2+ was to the and the of Ca2+ entry was The of was not different in TRPC3 KD myotubes compared with that of wild-type myotubes ± (TRPC3 KD) ± the amplitude of the transient was reduced in TRPC3 KD myotubes ± (TRPC3 KD) ± was not The of TRPC3 on examine expression of the TRPCs expressed in muscle and proteins in EC coupling in TRPC3 KD cell lysates from wild-type and TRPC3 KD myotubes were subjected to analysis The of analysis that TRPC1 was up-regulated (1.46 ± in to the of TRPC3, the expression of and were the proteins in expression triadin, junctophilin 1 and calsequestrin in expression ± 0.32-, 1.91 ± and 1.42 ± respectively) with the reduction of TRPC3 TRPC3, proteins are to with RyR1 and have been shown to regulate RyR1 (20Brady A.J. Annu. Rev. Physiol. 1964; 26: 341-356Crossref PubMed Scopus (20) Google Scholar, 21Sandow A. Pharmacol. Rev. 1965; 17: 265-320PubMed Google Scholar, A. N. Biophys. PubMed Scopus Google Scholar). by were with to examine was in the of proteins with RyR1 with the of TRPC3 of TRPC3 with RyR1 was in TRPC3 KD myotubes not the proteins expression was we found that was an of RyR1 with ± and ± not CSQ, in the TRPC3 KD myotube In study, TRPC3 in skeletal muscle myotubes was using a to small interference RNA. One (TRPC3 KD, a reduction in mRNA and reduction in protein from were subjected to Ca2+ imaging and Mn2+ quench to examine the functional of TRPC3 in muscle cells. were by biochemical to of the functional TRPC3 KD myotubes a significantly decreased gain of EC coupling, which is as a decreased cytosolic Ca2+ transient during EC coupling In with the that the Ca2+ for muscle contraction is Ca2+ release through RyR1 as a result of a physical interaction between RyR1 and the DHPR during skeletal EC coupling (21Sandow A. Pharmacol. Rev. 1965; 17: 265-320PubMed Google Scholar), RyR1 in TRPC3 KD myotubes was significantly reduced we store depletion as the cause for reduction by that the SR Ca2+ content is the same in wild-type and TRPC3 KD myotubes and and that the of is it is that the reduced cytosolic Ca2+ transient during EC coupling in TRPC3 KD myotubes from a direct reduction of RyR1 This is by the that in to a decreased gain of EC coupling, the of TRPC3 is with a decrease in the gain of Ca2+ release in to direct activation of RyR1 by caffeine that the reduced EC coupling and release with protein expression are: 1) by and CSQ, it is possible that expression tightly Ca2+ is to the for Ca2+ release the reticulum store 2) the coupling of RyR1 activation to the Ca2+ is are that both proteins have been in coupling RyR1 to Ca2+ release from the N. M. M. PubMed Scopus Google Scholar, N. B. M. PubMed Scopus Google Scholar, J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, Biophys. J. 2002; 82: Full Text Full Text PDF PubMed Scopus Google Scholar). One of was that TRPC3 was the because TRPC3 be with RyR1 (18Kiselyov K.I. Shin D.M. Wang Y. Pessah I.N. Allen P.D. Muallem S. Mol. Cell. 2000; 6: 421-431Abstract Full Text Full Text PDF PubMed Scopus (141) Google Scholar) and the current be by and of which are to TRPC3 current G. J.D. E.H. Allen P.D. Pessah I.N. Proc. Natl. Acad. Sci. U. S. A. 2004; PubMed Scopus Google Scholar). This was as the of of TRPC3 KD myotubes was not significantly different from that of type ± (TRPC3 KD) ± In addition, these that the decreased gain in EC coupling was not secondary to a decreased possible between the reduced RyR1 and the absence of TRPC3 is the of and direct of RyR1 function by the in the of with RyR1 B and has been previously to be an direct protein of RyR1 Biophys. Mol. Biol. 2004; PubMed Scopus Google Scholar), and of the primary skeletal of triadin, in the of Ca2+ release in the absence of extracellular Ca2+ and a decrease in gain in the of extracellular Ca2+ S. J. A. C. S. L. M. I. J. Biol. Chem. 2005; 280: Full Text Full Text PDF PubMed Scopus Google Scholar). This is in with is the that in the cells, Ca2+ release was not different from protein that with RyR1 in TRPC3 KD myotubes is has been shown to between and SR membrane via its which has a for and its C which an SR region K. S. K. M. M. K. H. J. Cell Biol. 2001; PubMed Scopus Google Scholar). with the of the of RyR1 for in the mechanism by which an in expression decrease RyR1 function is not The that is a functional interaction between TRPC3 and RyR1 is by the that expression of TRPC3 was by the expression of RyR1 in myotubes of TRPC3 expression by RyR1 was with wild-type and primary myotubes and indicating that is not on the of the cells. although the expression of two of the TRPCs expressed in skeletal muscle, and is in TRPC3 KD is an expression of TRPC1 through TRPC channels of endogenous TRPC1, TRPC3, and in X. J. Biol. Chem. 2005; 280: Full Text Full Text PDF PubMed Scopus Google Scholar) and the of TRPC1 and TRPC3 to in a cell X. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar), it is that TRPC1 and TRPC3 are in TRPC channels in it is that the in the expression of TRPC1 found is to for the absence of TRPC3 when the of is and the that TRPC3 role in in wild-type myotubes B and Studies with neurons have that TRPC3 is highly expressed in the cell and the required for its not that with X. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). The studies conclude that TRPC3 is essential for the guidance of growth cone in neurons (15Li Y. Jia Y.C. Cui K. Li N. Zheng Z.Y. Wang Y.Z. Yuan X.B. Nature. 2005; 434: 894-898Crossref PubMed Scopus (374) Google Scholar). In the same we found that during differentiation of primary wild-type myoblasts to expression of TRPC3 after differentiation 1) and then decreased 19Lee E.H. Allen P.D. Biophys. J. 2004; 86 (abstr.): 61Google and the differentiated myotubes on still expressed TRPC3 than myoblasts ± in the case of mouse skeletal muscle, regulated TRPC3 expression is with muscle cell although its role is not In in we roles of TRPC3 in mouse skeletal We found that appears to be a direct functional interaction between RyR1 and TRPC3 when the gain of the RyR1 depletion of the Ca2+ It is possible either or in to direct the of and with the absence of TRPC3 may a role in RyR1 that TRPC is not the and because of an of the expression of TRPC1, which is to be a in channels in it was not possible to in function with the of We Dr. Jianjie for the kind gift of with
30
Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol
Thomas Hofmann, Alexander G. Obukhov, Michael Schaefer et al. · Nature · 1999 · 1.5K citations
Yan Li, Yichang Jia, Kai Cui et al. · Nature · 2005 · 443 citations